Endo Pharma Agrees to Pull Abuse-Deterrent Opioid http://www.medscape.com/viewarticle/882578 Endo Pharmaceuticals has agreed to remove its abuse-deterrent extended-release formulation of oxymorphone (Opana ER) from the US market, about a month after the US Food and Drug Administration (FDA) asked the company to stop selling the pain medication. In a statement, the company said it “continues to […]
Filed under: General Problems | 3 Comments »